Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.

Autor: Sivapalasingam S; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Lederer DJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Bhore R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Hajizadeh N; Institute for Clinical Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, New York, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, New York, USA., Criner G; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA., Hosain R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Mahmood A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Giannelou A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Somersan-Karakaya S; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., O'Brien MP; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Boyapati A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Parrino J; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Musser BJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Labriola-Tompkins E; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Ramesh D; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Purcell LA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Gulabani D; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Kampman W; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Waldron A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Ng Gong M; Department of Medicine, Montefiore-Moses, Bronx, New York, USA., Saggar S; Department of Infectious Disease, Holy Name Medical Center, Teaneck, New Jersey, USA., Sperber SJ; Department of Infectious Disease, Hackensack Meridian School of Medicine and Hackensack University Medical Center, Hackensack, New Jersey, USA., Menon V; Department of Medicine, NYC Health + Hospitals/Lincoln, Bronx, New York, USA., Stein DK; Department of Medicine, Jacobi Medical Center, Bronx, New York, USA., Sobieszczyk ME; Department of Medicine, Columbia University, New York, New York, USA., Park W; Pulmonary and Sleep Disorder Clinic, Valley Medical Center, Renton, Washington, USA., Aberg JA; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USAand., Brown SM; Department of Internal Medicine, Intermountain Medical Center and University of Utah, Salt Lake City, Utah, USA., Kosmicki JA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Horowitz JE; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Ferreira MA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Baras A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Kowal B; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Thomas DiCioccio A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Akinlade B; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Nivens MC; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Braunstein N; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Herman GA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Yancopoulos GD; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Weinreich DM; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Aug 24; Vol. 75 (1), pp. e380-e388.

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults.

Autor: Raffi F; CHU de Nantes, Nantes, France; †Grahame Hayton Unit, Royal London Hospital, London, United Kingdom; ‡Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom; §Hotel Dieu University Hospital, Paris, France; ‖Southwest CARE Center, Santa Fe, NM; ¶Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA; #Hennepin County Medical Center, Minneapolis, MN; **University of Puerto Rico School of Medicine, Rio Piedras, PR; ††Jacobi Medical Center, Bronx, NY; ‡‡Southwest Infectious Disease Clinical Research, Dallas, TX; §§Pacific Oaks Medical Group, Beverly Hills, CA; and ‖‖Gilead Sciences, Foster City, CA., Orkin C, Clarke A, Slama L, Gallant J, Daar E, Henry K, Santana-Bagur J, Stein DK, Bellos N, Scarsella A, Yan M, Abram ME, Cheng A, Rhee MS

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2017 Jun 01; Vol. 75 (2), pp. 226-231.